Brief: Tot Biopharm International's Unit Entered Into Commercialization License With Kexing Biopharm

BioDlink International

11/01/2022 11:46

Jan 11 (Reuters) - TOT BIOPHARM International Co Ltd
 1875.HK :
    * UNIT ENTERED INTO EXCLUSIVE COMMERCIALIZATION LICENSE &
COOPERATION AGREEMENT FOR OVERSEAS MARKETS WITH KEXING BIOPHARM
    * UNIT ENTITLED TO RECEIVE AN UPFRONT PAYMENT AND RESEARCH
AND
DEVELOPMENT PAYMENTS OF RMB30 MILLION
    * IN DEAL KEXING BIOPHARM IS GRANTED AN EXCLUSIVE LICENSE TO
COMMERCIALIZE IN ALL COUNTRIES AND REGIONS OTHER THAN CHINA
EUROPE, UK, US AND JAPAN

Further company coverage:  1875.HK 

 ((Reuters.Briefs@thomsonreuters.com;))